During the past decade, Diabetes and Endocrinology Specialists conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diabetes and Endocrinology Specialists" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Novartis" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored, "InteKrin Therapeutics, Inc." with 1 trials sponsored and "Mylan Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes and Endocrinology Specialists" #1 collaborator was "Mylan GmbH" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes and Endocrinology Specialists" are "Diabetes Mellitus, Type 2" (4 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Diabetes Mellitus, Type 1" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Diabetes and Endocrinology Specialists" in a lesser frequency.

Most popular intervention types in "Diabetes and Endocrinology Specialists" are "Drug" (9 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AC2993" (4 trials), "vildagliptin" (2 trials), "Eversense® CGM system" (1 trials) and "FlexPen NovoLog®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes and Endocrinology Specialists" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes and Endocrinology Specialists". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Diabetes and Endocrinology Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes and Endocrinology Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".